CN Stock MarketDetailed Quotes

688373 Shanghai Micurx Pharmaceutical

Watchlist
  • 4.86
  • +0.57+13.29%
Market Closed Sep 30 15:00 CST
3.18BMarket Cap-6403P/E (TTM)

Shanghai Micurx Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Shanghai Micurx Pharmaceutical Q2 2024 Earnings Date

Currency：CNYAug 29, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
27.72M
--
+11.63%
Net Income
--
-99.17M
--
-43.80%
Analyst Rating
Strong Buy

Oct 2, 2024

Shanghai Micurx Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 260.000M--
--2024/FY-- / 166.000M--
Mar 28, 20242023/FY90.776M / 103.000M--
Mar 25, 20232022/FY48.207M / 50.000M--
--2021/FY7.660M / ----
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 260.000M--
--2024/FY-- / 166.000M--
Mar 28, 20242023/FY90.776M / 103.000M--
Mar 25, 20232022/FY48.207M / 50.000M--
--2021/FY7.660M / ----

Unlock Free Earnings Estimates

Shanghai Micurx Pharmaceutical Earnings Reports

  • Shanghai Mengke Pharmaceutical Co., Ltd. 2024 Semi-Annual Report

    Aug 28 12:00 ET

  • Summary of the 2024 semi-annual report of Shanghai Mengke Pharmaceutical Co., Ltd.

    Aug 28 12:00 ET

  • Shanghai Mengke Pharmaceutical Co., Ltd. Report for the first quarter of 2024

    Apr 25 12:00 ET

  • Summary of the 2023 Annual Report of Shanghai Mengke Pharmaceutical Co., Ltd.

    Mar 27 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 2, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data